Center for Research in Transplantation and Translational Immunology, Nantes Université, CHU Nantes, INSERM, UMR 1064, F-44000 Nantes, France.
CIC Neurologie, CHU Nantes, F-44093 Nantes, France.
Int J Mol Sci. 2022 Oct 12;23(20):12142. doi: 10.3390/ijms232012142.
Multiple sclerosis is a chronic and inflammatory disease of the central nervous system. Although this disease is widely studied, many of the precise mechanisms involved are still not well known. Numerous studies currently focusing on multiple sclerosis highlight the involvement of many major immune cell subsets, such as CD4+ T cells, CD8+ T cells and more recently B cells. However, our vision of its pathology has remained too broad to allow the proper use of targeted therapeutics. This past decade, new technologies have emerged, enabling deeper research into the different cell subsets at the single-cell level both in the periphery and in the central nervous system. These technologies could allow us to identify new cell populations involved in the disease process and new therapeutic targets. In this review, we briefly introduce the major single-cell technologies currently used in studies before diving into the major findings from the multiple sclerosis research from the past 5 years. We focus on results that were obtained using single-cell technologies to study immune cells and cells from the central nervous system.
多发性硬化症是一种中枢神经系统的慢性炎症性疾病。尽管对这种疾病进行了广泛的研究,但许多涉及的确切机制仍不为人知。目前有许多针对多发性硬化症的研究强调了许多主要免疫细胞亚群的参与,如 CD4+ T 细胞、CD8+ T 细胞,以及最近的 B 细胞。然而,我们对其病理学的认识仍然过于广泛,无法正确使用靶向治疗。在过去的十年中,新技术的出现使我们能够在单细胞水平上深入研究外周血和中枢神经系统中不同的细胞亚群。这些技术可以帮助我们识别参与疾病过程的新细胞群和新的治疗靶点。在这篇综述中,我们简要介绍了目前在研究中使用的主要单细胞技术,然后深入探讨过去 5 年多发性硬化症研究的主要发现。我们重点介绍了使用单细胞技术研究免疫细胞和中枢神经系统细胞的结果。